A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor

Tinea Versicolor Clinical Trial

Official title:
A Randomized, Double-Blinded, Aqueous Gel-Controlled Dose Escalating Trial to Study the Safety and Antimicrobial Efficacy of DBI-002 Probiotic vs. Aqueous Gel and Vehicle Gel vs. Aqueous Gel in Adults With Tinea Versicolor

Status Completed

Clinical Trial Summary

A Randomized, Double-Blinded, Aqueous Gel-Controlled Dose Escalating Trial to Study the Safety and Antimicrobial Efficacy of DBI-002 Probiotic vs. Aqueous Gel and Vehicle Gel vs. Aqueous Gel in Adults with Tinea Versicolor (DBI-202).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04937920
Study type	Interventional
Source	DermBiont, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	March 16, 2021
Completion date	November 4, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00830388` - Ketoconazole Foam 2% for the Treatment of Versicolor	Phase 4
Completed	`NCT05862714` - Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Patients With Pityriasis Versicolor	Phase 1
Not yet recruiting	`NCT05730244` - A Study of the Clinical Efficacy and Safety of 100% Cassia Alata Extract Against Tinea Versicolor	Phase 1
Completed	`NCT04110834` - Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel	Phase 2
Completed	`NCT04110860` - Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel	Phase 2
Completed	`NCT06305637` - A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.	Phase 1